Finally, PEA reduced phosphorylated tau protein overexpression and rescued cognitive functioning, further strengthening the potential properties of the compound as a therapeutic agent in AD (Scuderi et al., 2014). The gene discussed is MAPT; the disease is Alzheimer disease.